These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 15183159

  • 1. Evaluating the validity of animal models for research into therapies for immune-based disorders.
    't Hart BA, Amor S, Jonker M.
    Drug Discov Today; 2004 Jun 15; 9(12):517-24. PubMed ID: 15183159
    [Abstract] [Full Text] [Related]

  • 2. Virtues and pitfalls of EAE for the development of therapies for multiple sclerosis.
    Steinman L, Zamvil SS.
    Trends Immunol; 2005 Nov 15; 26(11):565-71. PubMed ID: 16153891
    [Abstract] [Full Text] [Related]

  • 3. Preclinical assessment of therapeutic antibodies against human CD40 and human interleukin-12/23p40 in a nonhuman primate model of multiple sclerosis.
    't Hart BA, Hintzen RQ, Laman JD.
    Neurodegener Dis; 2008 Nov 15; 5(1):38-52. PubMed ID: 18075274
    [Abstract] [Full Text] [Related]

  • 4. Considerations for the sensible use of rodent models of inflammatory disease in predicting efficacy of new biological therapeutics in the clinic.
    Arnett HA, Viney JL.
    Adv Drug Deliv Rev; 2007 Sep 30; 59(11):1084-92. PubMed ID: 17804112
    [Abstract] [Full Text] [Related]

  • 5. Development and validation of gene therapies in autoimmune diseases: Epidemiology to animal models.
    Leung PS, Shu SA, Kenny TP, Wu PY, Tao MH.
    Autoimmun Rev; 2010 Mar 30; 9(5):A400-5. PubMed ID: 20035901
    [Abstract] [Full Text] [Related]

  • 6. The translation of drug efficacy from in vivo models to human disease with special reference to experimental autoimmune encephalomyelitis and multiple sclerosis.
    Bolton C.
    Inflammopharmacology; 2007 Oct 30; 15(5):183-7. PubMed ID: 17943249
    [Abstract] [Full Text] [Related]

  • 7. New directions in MS therapeutics: vehicles of hope.
    Fox RJ, Ransohoff RM.
    Trends Immunol; 2004 Dec 30; 25(12):632-6. PubMed ID: 15530830
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Drug insight: using monoclonal antibodies to treat multiple sclerosis.
    Hohlfeld R, Wekerle H.
    Nat Clin Pract Neurol; 2005 Nov 30; 1(1):34-44. PubMed ID: 16932490
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Immunopathogenesis and immunotherapy of multiple sclerosis.
    Hemmer B, Nessler S, Zhou D, Kieseier B, Hartung HP.
    Nat Clin Pract Neurol; 2006 Apr 30; 2(4):201-11. PubMed ID: 16932551
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Glucocorticoids in multiple sclerosis and experimental autoimmune encephalomyelitis.
    Reichardt HM, Gold R, Lühder F.
    Expert Rev Neurother; 2006 Nov 30; 6(11):1657-70. PubMed ID: 17144780
    [Abstract] [Full Text] [Related]

  • 14. Animal models for multiple sclerosis.
    Owens T.
    Adv Neurol; 2006 Nov 30; 98():77-89. PubMed ID: 16400828
    [No Abstract] [Full Text] [Related]

  • 15. EAE: pitfalls outweigh virtues of screening potential treatments for multiple sclerosis.
    Ransohoff RM.
    Trends Immunol; 2006 Apr 30; 27(4):167-8. PubMed ID: 16513422
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. From treatment of experimental allergic encephalomyelitis to clinical trials in multiple sclerosis.
    Steinman L, Lindsey JW, Alters S, Hodgkinson S.
    Immunol Ser; 1993 Apr 30; 59():253-60. PubMed ID: 8461390
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Therapeutic potential of immunostimulatory monoclonal antibodies.
    Gray JC, Johnson PW, Glennie MJ.
    Clin Sci (Lond); 2006 Aug 30; 111(2):93-106. PubMed ID: 16831129
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.